Immunogenic cell envelope preparations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4248862
SERIAL NO

06012857

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An antigenically-active cell envelope fraction from bacterial cells, especially Bordetella pertussis, may be isolated by disrupting the cells, separating the cell envelopes from the other cell components, extracting the separated envelopes with a solution of a zwitterionic surfactant and precipitating the cell envelope preparation from the resulting extract by the addition of a lower alkyl (C.sub.1 to C.sub.5) alcohol, preferably ethanol. The preferred extractant is an N, N, N-trialkyl zwitterionic compound especially an N, N, N-trialkyl-.alpha.-amino acid or an N, N, N-trialkyl amine oxide. The cell envelope fraction obtained from B. pertussis is highly protective against whole bacteria when tested by standard vaccine mouse potency assay and has a greatly reduced lipopolysaccharide content compared with either whole cells or crude cell envelopes, greatly reducing the risk of undesirable side-effects from vaccination.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MICROBIOLOGICAL RESEARCH AUTHORITY;THE SECRETARY OF STATE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ellwood, Derek C Salisbury, GB2 5 50
Manchee, Richard J Salisbury, GB2 1 7
Robinson, Andrew Salisbury, GB2 95 956

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation